Bausch Health
454 hedge funds and large institutions have $38.7B invested in Bausch Health in 2014 Q3 according to their latest regulatory filings, with 54 funds opening new positions, 163 increasing their positions, 162 reducing their positions, and 75 closing their positions.
12% more funds holding in top 10
Funds holding in top 10: 60 → 67 (+7)
1% more call options, than puts
Call options by funds: $1.39B | Put options by funds: $1.37B
1% more capital invested
Capital invested by funds: $38.3B → $38.7B (+$425M)
1% more repeat investments, than reductions
Existing positions increased: 163 | Existing positions reduced: 162
2.25% less ownership
Funds ownership: 90.34% → 88.09% (-2.2%)
4% less funds holding
Funds holding: 475 → 454 (-21)
28% less first-time investments, than exits
New positions opened: 54 | Existing positions closed: 75
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FTCM
Fir Tree Capital Management
New York
|
+$158M |
| 2 |
JP
Jana Partners
New York
|
+$153M |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$136M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$124M |
| 5 |
LPC
Lone Pine Capital
Greenwich,
Connecticut
|
+$107M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$402M |
| 2 |
Norges Bank
Oslo,
Norway
|
-$303M |
| 3 |
Viking Global Investors
Stamford,
Connecticut
|
-$222M |
| 4 |
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
|
-$206M |
| 5 |
OH
Orbis Holdings
Hamilton,
Bermuda
|
-$187M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
526
Winslow Capital Management
Minneapolis,
Minnesota
| – | -$4K | -29 | Closed |
|
|
LWCFA
527
Loring Wolcott & Coolidge Fiduciary Advisors
Boston,
Massachusetts
| – | -$3K | -24 | Closed |
|
528
AssetMark Inc
Concord,
California
| – | -$119 | -1 | -33% |
|
|
SCM
529
Suvretta Capital Management
New York
| – | +$119 | +1 | New |
|
BHC Hedge Fund Activity: Q3 2014 in Review
454 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in Bausch Health (BHC) for Q3 2014, worth a combined $38.7B — up 1.1% from $38.3B a quarter earlier.
Sellers outnumbered buyers: 75 funds closed out of BHC and 54 opened new positions — a net loss of 21 holders — while 162 trimmed existing stakes and 163 added.
The largest buyer was Fir Tree Capital Management, opening a new position worth an estimated $158M. The largest seller was Fidelity Investments, cutting an estimated $402M.
- 454 institutional investors held Bausch Health (BHC) as of Q3 2014, down from 475 in Q2 2014.
- Funds reported $38.7B of Bausch Health stock for Q3 2014, up 1.1% quarter-over-quarter.
- 54 funds opened new Bausch Health positions in Q3 2014 and 75 closed out, a net change of -21 holders.
- The largest Bausch Health buyer in Q3 2014 was Fir Tree Capital Management, an estimated $158M added.
- The largest Bausch Health seller in Q3 2014 was Fidelity Investments, an estimated $402M sold.
Based on aggregated 13F filings for Q3 2014.